Plasmin is not protective in experimental renal interstitial fibrosis1

Slides:

Advertisements

Similar presentations

Volume 62, Issue 6, Pages (December 2002)

Advertisements

Volume 70, Issue 1, Pages (July 2006)

Volume 78, Issue 3, Pages (August 2010)

Plasmin is not protective in experimental renal interstitial fibrosis1

Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells W. Qi, X. Chen, S. Twigg, T.S. Polhill,

Reduced expression of VAChT increases renal fibrosis

Volume 78, Issue 4, Pages (August 2010)

Volume 82, Issue 6, Pages (September 2012)

GAPDH as housekeeping gene at renal level

Volume 84, Issue 2, Pages (August 2013)

Volume 68, Issue 6, Pages (December 2005)

IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy J.-A. Moon,

Volume 56, Pages S31-S36 (July 1999)

Volume 86, Issue 3, Pages (September 2014)

Volume 66, Issue 6, Pages (December 2004)

Volume 69, Issue 10, Pages (May 2006)

Volume 63, Issue 4, Pages (April 2003)

Volume 80, Issue 9, Pages (November 2011)

Volume 63, Issue 5, Pages (May 2003)

Mast cells decrease renal fibrosis in unilateral ureteral obstruction

Volume 58, Issue 2, Pages (August 2000)

Volume 54, Issue 1, Pages (July 1998)

Volume 68, Issue 1, Pages (July 2005)

Heterozygous disruption of activin receptor–like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy José.

Volume 64, Issue 2, Pages (August 2003)

Volume 81, Issue 9, Pages (May 2012)

Volume 84, Issue 5, Pages (November 2013)

Volume 76, Issue 2, Pages (July 2009)

Volume 74, Issue 1, Pages (July 2008)

Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy Shinya Mizuno, Kunio Matsumoto, Toshikazu Nakamura

Volume 60, Issue 2, Pages (August 2001)

Volume 57, Issue 5, Pages (May 2000)

Volume 70, Issue 1, Pages (July 2006)

Reciprocal functions of hepatocyte growth factor and transforming growth factor-β1 in the progression of renal diseases: A role for CD44? Sandrine Florquin,

Volume 86, Issue 4, Pages (October 2014)

Jin H. Li, Xiao R. Huang, Hong-Jian Zhu, Richard Johnson, Hui Y. Lan

Volume 61, Issue 1, Pages (January 2002)

Saulo Klahr, Jeremiah J. Morrissey Kidney International

Izabella Z.A. Pawluczyk, Kevin P.G. Harris Kidney International

Volume 64, Issue 3, Pages (September 2003)

Effect of nitric oxide modulation on TGF-β1 and matrix proteins in chronic cyclosporine nephrotoxicity Fuad S. Shihab, Hong Yi, William M. Bennett, Takeshi.

Volume 75, Issue 6, Pages (March 2009)

Volume 58, Issue 6, Pages (December 2000)

Volume 82, Issue 2, Pages (July 2012)

Volume 83, Issue 6, Pages (June 2013)

Volume 54, Issue 4, Pages (October 1998)

Volume 56, Issue 2, Pages (August 1999)

Volume 78, Issue 1, Pages (July 2010)

M.-J. Wu, M.-C. Wen, Y.-T. Chiu, Y.-Y. Chiou, K.-H. Shu, M.-J. Tang

Volume 67, Issue 6, Pages (June 2005)

CD4+ T cells: a potential player in renal fibrosis

Volume 56, Issue 1, Pages (July 1999)

Volume 54, Issue 1, Pages (July 1998)

Volume 67, Issue 6, Pages (June 2005)

TGF-β type II receptor deficiency prevents renal injury via decrease in ERK activity in crescentic glomerulonephritis C.Y. Song, B.C. Kim, H.K. Hong,

Volume 58, Issue 5, Pages (November 2000)

Volume 58, Issue 4, Pages (October 2000)

Volume 65, Issue 2, Pages (February 2004)

Volume 76, Issue 8, Pages (October 2009)

Is complement a target for therapy in renal disease?

Sandrine Billet, Fréderick Aguilar, Camille Baudry, Eric Clauser

Kathryn J. Wiggins, Darren J. Kelly Kidney International

Jens Gaedeke, Nancy A. Noble, Wayne A. Border Kidney International

Volume 70, Issue 2, Pages (July 2006)

T-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis Masashi Haraguchi, Wayne A. Border, Yufeng Huang,

The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury? Richard E. Gilbert, Mark E. Cooper Kidney.

J. Ma, A. Weisberg, J.P. Griffin, D.E. Vaughan, A.B. Fogo, N.J. Brown

Volume 75, Issue 8, Pages (April 2009)

Volume 59, Issue 2, Pages (February 2001)

Volume 65, Issue 1, Pages (January 2004)

Presentation transcript:

Plasmin is not protective in experimental renal interstitial fibrosis1 Kristy L. Edgtton, Renae M. Gow, Darren J. Kelly, Peter Carmeliet, A. Richard Kitching Kidney International Volume 66, Issue 1, Pages 68-76 (July 2004) DOI: 10.1111/j.1523-1755.2004.00707.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Renal histopathology in plg+/+ and plg-/- mice. Interstitial renal fibrosis developed in both plasminogen-intact and plasminogen-deficient mice. Disease was moderate at day 7 in both plg+/+ mice (A) and plg-/- mice (B), and severe at day 21, again in both plg+/+ mice (C) and plg-/- mice (D) (high power, ×400, Sirius red stain, collagen appearing red). Kidney International 2004 66, 68-76DOI: (10.1111/j.1523-1755.2004.00707.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Accumulation of collagen in normal contralateral and obstructed kidneys from plg+/+ and plg-/- mice. Hydroxyproline assay demonstrates no difference at 7 days (A) and a small but significant reduction in collagen accumulation at day 21 (B) *P = 0.04. The dotted lines represent values for unobstructed normal mice on which operations have had not been performed. Kidney International 2004 66, 68-76DOI: (10.1111/j.1523-1755.2004.00707.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 Macrophage infiltrate in obstructed kidneys from plg+/+ and plg-/- mice. Photomicrographs of interstitial macrophages. At 7 days there was a moderately dense macrophage infiltrate in both plg+/+ (A) and plg-/- (B). At 21 days, the infiltrate in plg+/+ mice (C) was more dense than in plg-/- mice (D) (medium power, ×200, F4/80+ cells, black reaction product, nuclear fast red counterstain). (E) Semiquantitative analysis of macrophage infiltration, showing reduced infiltration at 21 days in mice deficient in plasminogen. Kidney International 2004 66, 68-76DOI: (10.1111/j.1523-1755.2004.00707.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 4 Analysis of transforming growth factor-β1 (TGF-β1) and βig-h3 mRNA in obstructed kidneys from plg+/+ and plg-/- mice at 7 and 21 days. TGF-β1 and βig-h3 mRNA are compared with the housekeeping gene 18S, with the βig-h3:TGF-β1 mRNA ratio providing an index of active to total TGF-β. Results are expressed in arbitrary units (AU) relative to plg+/+ mice at day 7. (A) There was a trend, but no significant difference (P = 0.114) to increased TGF-β1 mRNA at day 7, that was not continued at day 21. (B) There was no significant reduction in βig-h3 mRNA (P = 0.11 at 21 days). (C) There was a strong trend (P = 0.057 at either time point) to reduced βig-h3:TGF-β1 mRNA ratios in plg-/- mice. Kidney International 2004 66, 68-76DOI: (10.1111/j.1523-1755.2004.00707.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 5 Gelatin zymography showing pro-matrix metalloproteinase (MMP)-9 and active MMP-9, and pro-MMP-2 and active MMP-2 activity in kidneys from plg+/+ and plg-/- mice. Pro-MMP-2 but not active MMP-2 activity is measurable in contralateral kidneys and active MMP-2 is increased in obstructed kidneys from plg+/+ mice, but to a lesser degree in plg-/- mice. Plasmin is not required for MMP-9 activation. Representative samples from each group of mice were chosen. Kidney International 2004 66, 68-76DOI: (10.1111/j.1523-1755.2004.00707.x) Copyright © 2004 International Society of Nephrology Terms and Conditions